跳至主要内容
临床试验/NCT02668861
NCT02668861Unknown3 期

Influence of Oral Vitamin D3 on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels

The First Affiliated Hospital of Shanxi Medical University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
40
试验地点
1
主要终点
VAS evaluation of usual symptoms in patients with CRSwNP

研究概览

简要总结

The purpose of the study is to test the clinical efficacy of oral Vitamin D3 on Wound Healing in patients with Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels After Endonasal Endoscopic Sinus Surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Chronic Rhinosinusitis with nasal polyps
  • Be 18-60 years old of Chinese people and of either sex,the Han nationality
  • Vitamin D level of less than 30 ng/ml

排除标准

  • Women must not be pregnant, breast feeding
  • Chronic oral corticosteroid therapy
  • History of physician-diagnosed nephrolithiasis
  • Chronic diseases( diabetes,Hypertension,renal insufficiency, severe liver disease) 5.prior surgeries of the paranasal sinuses
  • With an upper respiratory tract infection within 4 weeks of entering the study

研究组 & 干预措施

Vitamin D+Budesonide Nasal Spray

Experimental

Vitamin D 4000IU/day for 8 weeks + Budesonide Nasal Spray 128ug/d for 8 week

干预措施: Vitamin D (Drug)

Vitamin D+Budesonide Nasal Spray

Experimental

Vitamin D 4000IU/day for 8 weeks + Budesonide Nasal Spray 128ug/d for 8 week

干预措施: Budesonide Nasal Spray (Drug)

placebo+Budesonide Nasal Spray

Placebo Comparator

Placebo for 8 weeks + Budesonide Nasal Spray128ug/d for 8 week

干预措施: Budesonide Nasal Spray (Drug)

placebo+Budesonide Nasal Spray

Placebo Comparator

Placebo for 8 weeks + Budesonide Nasal Spray128ug/d for 8 week

干预措施: placebo (Other)

结局指标

主要结局

VAS evaluation of usual symptoms in patients with CRSwNP

时间窗: at 8 weeks after first drug intake

The evaluated symptoms were nasal obstruction, anterior nasal discharge and post-nasal drip, smelling reduction and facial pain

Questionnaire:SNOT-20 evaluates the quality of Life

时间窗: at 8 weeks after first drug intake

Change of Lund-Kennedy scores

时间窗: at 8 weeks after first drug intake

次要结局

  • Inflammatory mediators in serum(8 weeks)
  • Histologic analysis of nasal mucosa(8 weeks)

研究者

发起方
The First Affiliated Hospital of Shanxi Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jun Tian

Associate Professor

The First Affiliated Hospital of Shanxi Medical University

研究点 (1)

Loading locations...

相似试验